Adenocarcinoma lung france: 20 years, new: This article explores the topic in depth.
Therefore,
Adenocarcinoma lung france: 20 years. Nevertheless, new: In addition,
Adenocarcinoma lung france: 20 years,:
Since 2000, 3 -year survival of patients with lung adenocarcinoma in France has doubled. Consequently. Similarly, This is what we learn from a study conducted by the French group KBP-2020-CHG (College of pulmonologists from general hospitals). Consequently, based on prospective data from French public establishments, dating from 2000, 2010 and 2020. However, Researchers describe an improvement in 3 years survival. Moreover, accentuated over the last 10 years, but also point to an increase in the proportion of women affected.
“These changes observed are probably the result of multifactorial progress in the management of primitive cancer of the lung. In addition. including progress in imaging examinations allowing earlier detection, better definition of metastatic disease, better classification and better characterization of histology with immunomarcation”, estimate the authors, also citing “Surgical progress (mini-invasive techniques, robotics, adenocarcinoma lung france: 20 years, new peri-operative strategies)”. For example, This study is published in adenocarcinoma lung france: 20 years, The New England Journal of Medicine Evidence.
The team also attributes these figures to the development of molecular genetics platforms that allowed faster. extensive research of mutations, as well as the discovery of anomalies that can be targeted. Reinforced hypotheses. according to the DRS Fiona Stanaway. Armando Teixeira-Pinto, authors of an associated editorial, by American data on the contribution of targeted therapies in patients with non-small cell cancer.
Almost a proportion of women in 20 years – Adenocarcinoma lung france: 20 years, – Adenocarcinoma lung france: 20 years, new
In 2000. 2010. 2020, the CPHG carried out three studies with a comparable methodology including all the patients diagnosed and supported by a public hospitals network (excluding academic centers and university hospitals). According to their data. if adenocarcinomas represented less than a third of lung cancers in 2000, they are currently the majority adenocarcinoma lung france: 20 years, new histological subtype (56.1 %). As for 3 -year survival, it was 16.3 % in 2000, 21.2 % in adenocarcinoma lung france: 20 years, 2010 and 38.6 % in 2020. The global median survival was 8.5 months in 2000 and 20.7 months in 2020.
The authors finally observe that women represent 24.5 % of cases in 2000 and 40.4 % in 2020 and that the share of people over 80 has doubled (6.4 against 12.7 %). Other groups of patients are also more affected. non-smokers and people with high body mass index, “Changing the typical profile of patients with lung cancer.” However. this evolution remains «Minima» by editorialists. who underline “The late establishment of measures for tobacco control in France compared to other European countries”.
An early diagnosis associated with 84 % survival
For all cohorts. being a woman, having changes targeted by therapies and an early stage adenocarcinoma lung france: 20 years, new disease was associated with better survival at 3 years. Thus, in 2020, survival at 3 years was 45.1 % in women (18.3 % adenocarcinoma lung france: 20 years, in 2000) against 34.2 % in men (15.6 % in 2000); The survival of patients with mutations EGFR, ALK et ROS1 Treaties by targeted therapy was 36 % against 18.5 % for patients who do not have these changes; And the survival of patients diagnosed at an early stage was 84 % against 21.3 % for those diagnosed at the metastatic stage. In metastatic patients without mutation, first -line immunotherapy offered better survival than without immunotherapy (36.2 % and 21 months against 14.3 % and 4.2 months). These data illustrate the importance of access to technical innovation. the implementation of a national lung cancer screening program for early diagnosis.
Further reading: I saved myself – “Thanks to the ovarian adenocarcinoma lung france: 20 years, new fabric transplant, I realize!” “ – The Curie Institute and the Diaconesses Croix hospital group… – Second skin cancer: codified surveillance | The doctor’s daily life | Specialties – My discovery of this ruby fruit that boosts good cholesterol naturally – Clermont. A represented stop for relatives of patients suffering from Alzheimer’s opening in September.
Further reading: The advice of a Béarnaise dietician-nutritionist: counting the calories is useless when you want to lose weight – high increase in the number of cases in France – Colorectal cancer: AI allows the blood detection test – MALADIE MALADIE is launching a free screening kit for 18-25 year olds in order to combat the rise in sexual infections – New recommendations to improve neonatal hearing screening.
